Description
This session will include presentations of pulse field ablation for linear lesions and posterior wall isolation.
Learning Objectives
- Describe the risks vs benefits associated with the use of PFA for posterior wall isolation and linear ablation.
- Revise the recently available data on catheter ablation strategies using PFA technologies outside the pulmonary veins.
- Evaluate the added benefit of substrate ablation in addition to pulmonary vein isolation for the treatment of AF.
Session Chair(s)
Vidal Essebag, MD, PhD
Presentation
Feasibility and Durability of Pulmonary Vein Isolation and Posterior Left Atrial Wall Ablation Using Nanosecond Pulse Field Ablation: A First-in-Human Clinical Experience
Presenter(s): Petr Neuzil, MD, PhD, Jan Petru, MD, Moritoshi Funasako, MD, PhD, Jacob S. Koruth, MD, Pavel Hala, Jan Skoda, Vivek Y. Reddy, MD
Pulsed field ablation for pulmonary vein isolation with or without posterior wall isolation in patients with persistent atrial fibrillation: A multicenter retrospective study
Presenter(s): Marta Lorente-Ros, MD, Angel Armas, MD, Sebastian D. Santos Patarroyo, Daniel Zapata, MD, Robert N. Kerley, MBChB, Isabella Alviz, MD, David T. Keane, MD, PhD, Seth McClennen, MD, Victor Nauffal, MD, Ely A. Gracia, MD, Sunil Kapur, MD, Bruce A. Koplan, MD, Paul C. Zei, MD, PhD, Thomas M. Tadros, MD, MPH, Nathaniel Steiger, MD, Usha B. Tedrow, MD, MS, William H. Sauer, MD, Jorge Romero, MD
Mitral isthmus block and recurrent peri-mitral reentry tachycardia in patients undergoing pulsed field ablation for longstanding persistent atrial fibrillation
Presenter(s): Martin Fiala, MD, Frantisek Lehar, MD, Michal Cernosek, MD, Jiri Jez, Veronika Bulkova, MHA, MSci, PhD, Moritoshi Funasako, MD, PhD, Lukas Rybka, Ondrej Toman, MD, Petr Kala
Anterior Mitral Line with Pulsed Field Ablation: Acute and Intermediate-term Outcomes
Presenter(s): Beom Soo Kim, MD, Ibrahim Selevany, Alexander Kushnir, MD, PhD, Lior Jankelson, MD, PhD, Felix Yang, MD, Michael A. Spinelli, MD, Douglas Holmes, MD, Anthony Aizer, MD, MS, Larry A. Chinitz, MD, Chirag R. Barbhaiya, MD
Clinical outcomes of patients with mitral isthmus dependent atrial flutter undergoing anterior and posterolateral mitral isthmus lines with pulsed field ablation.
Presenter(s): Robert N. Kerley, MBChB, Angel Armas, MD, Marta Lorente-Ros, MD, Sebastian D. Santos Patarroyo, Isabella Alviz, MD, Daniel Zapata, MD, Daniel Campos-Villareal, Daniela Hincapie Tabares, MD, Thomas M. Tadros, MD, MPH, William H. Sauer, MD, Paul C. Zei, MD, PhD, David T. Keane, MD, PhD, Jorge Romero, MD
Disclosures
Petr Neuzil:
- EBR Systems (Research (Contracted Grants for PIs and Named Investigators only) - Research)
- Boston Scientific (Honoraria/Speaking/Consulting Fee - Consulting)
- Medtronic (Honoraria/Speaking/Consulting Fee - Consulting)
- Abbott (Honoraria/Speaking/Consulting Fee - Research)
- Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Independent Contractor (including contracted research))
- CardioFocus, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
- Farapulse (Honoraria/Speaking/Consulting Fee - Consulting)
- Kardium (Honoraria/Speaking/Consulting Fee - Research)
Marta Lorente-Ros:
- Nothing Relevant to Disclose
Martin Fiala:
- Nothing Relevant to Disclose
Beom Soo Kim:
- Nothing Relevant to Disclose
Robert Kerley:
- Nothing Relevant to Disclose
To view all Heart Rhythm 2025 Faculty Disclosures, please click
here.
Education Framework
Supraventricular Tachyarrhythmias
-- AFib and Flutter - Catheter Ablation
-- 143. Know the methods, techniques, associated tools, and equipment including emerging technologies to perform catheter ablation of atrial fibrillation and flutter.